Incyte Corporation: “That one makes no sense that it’s down here. I think you got a really good one. I think you should maybe buy even more than you have. I don’t get it. This company actually makes money. It’s real good. I think the big boys are going to come to it. Nice call.”
Nautilus Biotechnology: “That’s an Andreessen Horowitz-[backed] company. Look, this is one is too small for me to just point-blank say, ‘You’re absolutely right. We’ve got to love it.’ I’ve got to do more work on it. It does seem very strange because [Amazon founder Jeff] Bezos, it looks like they’re very involved . It’s an odd one. Let me do some work.”
Corning: “They’re unassailable in terms of their manufacturing, but in terms of making money with that manufacturing, there are so many other better companies. I cannot recommend their stock.”
Icahn Enterprises: “No. I think it’s variable, [which] is the problem. I don’t know what’s in Icahn Enterprises. He doesn’t tell us. I wish I knew, so therefore it’s too much of a black box for me to recommend.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
